NFC
TAK icon

Northeast Financial Consultants’s Takeda Pharmaceutical TAK Stock Holding History

Northeast Financial Consultants’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-27,122
Closed -$412K – 311
2020
Q1 		$412K Hold
27,122
– – 0.05% 173
2019
Q4 		$535K Sell
27,122
-26,322
-49% -$504K 0.05% 178
2019
Q3 		$919K Hold
53,444
– – 0.09% 140
2019
Q2 		$946K Buy
+53,444
New +$973K 0.1% 134

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Northeast Financial Consultants's TAK Position: Q2 2020 in Review

Northeast Financial Consultants sold out of Takeda Pharmaceutical (TAK) in Q2 2020, closing a stake of 27,122 shares — an estimated $412K sold.

Northeast Financial Consultants first reported a position in TAK in Q2 2019 and held it in 4 quarters. The position peaked at $946K in Q2 2019. 309 funds tracked by Wall St. Rank hold TAK as of Q2 2020.

  • Northeast Financial Consultants reported no remaining Takeda Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Northeast Financial Consultants sold 27,122 Takeda Pharmaceutical shares in Q2 2020, an estimated $412K.
  • Northeast Financial Consultants first reported a position in Takeda Pharmaceutical in Q2 2019 and held it in 4 quarters.
  • Northeast Financial Consultants's Takeda Pharmaceutical position peaked at $946K in Q2 2019.
  • 309 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2020.

Based on Northeast Financial Consultants's 13F filing for Q2 2020, filed 30 Jul 2020.